Ovid Therapeutics Inc. Increase (Decrease) in Deferred Liabilities
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2019-03-07
- Ovid Therapeutics Inc. increase (decrease) in deferred liabilities for the quarter ending 2017-12-31 was $0.00.
- Ovid Therapeutics Inc. increase (decrease) in deferred liabilities for the quarter ending 2017-09-30 was $725.66K.
- Ovid Therapeutics Inc. increase (decrease) in deferred liabilities for the quarter ending 2017-06-30 was $681.46K, a 18.56% increase year-over-year.
- Ovid Therapeutics Inc. increase (decrease) in deferred liabilities for the quarter ending 2017-03-31 was -$1.18M.
- Ovid Therapeutics Inc. increase (decrease) in deferred liabilities for fiscal 2017 was $229.00K.
- Ovid Therapeutics Inc. increase (decrease) in deferred liabilities for fiscal 2016 was -$229.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $725.66K derived: sum of 2 quarters · filed 2019-03-07 | $1.41M derived: sum of 3 quarters · filed 2019-03-07 | $229.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $725.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.41M derived: sum of 2 quarters · filed 2018-11-08 | $229.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $681.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$496.66K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | -$1.18M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$229.00K 10-K · filed 2018-03-29 | |||
| 2016-06-30 | $574.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$21.10K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$595.86K 10-Q · filed 2017-06-13 |